Completed

NCT Number: NCT07010796

Treatment of Adipose Tissue and Skin Laxity at the Buttocks by PDLLA, US and RF

Local body fat and lax skin is treated with a combined approach of PDLLA injections and topical ultrasound and radiofrequency.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Local Fat Deposits

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Elite Laser Clinic Organization

Madrid, 28005, Spain

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adults over 18 years
patients eligible to be treated with radiofrequency and ultrasound
all genders

Exclusion criteria

patients displaying contraindications for treatment with radiofrequency and ultrasound
pregnancy
immune diseases
active virus infections

Treatment and study plan

Alma Prime X

Device

Alma Prime x is a platform that provides applicators for radiofrequency and ultrasound.

Primary outcomes

change of fat deposits

Time frame: From enrollment to the end of treatment at 2 months

Sponsors and collaborators

Lead sponsor

Pablo Naranjo García, MD

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jun 8, 2025
Registry last updated: Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.